CLPT

Clearpoint Neuro Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 1/10
  • Momentum↑ 5/10
Clearpoint Neuro sales and earnings growth
CLPT Growth
Low
  • Revenue Y/Y↑ 12.83%
  • EPS Y/Y↓ -23.53%
  • FCF Y/Y↓ -52.31%
Clearpoint Neuro gross and profit margin trends
CLPT Profitability
Fair
  • Gross margin ↑ 61.30%
  • EPS margin↓ -67.40%
  • ROIC↓ -71.80%
Clearpoint Neuro net debt vs free cash flow
CLPT Risk
Great
  • Debt / Equity↑ 2.3
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -36.1

Clearpoint Neuro stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗